Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05004610 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hypertonic Lactate After Cardiac Arrest

Study acronym: LATTE
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised
    v5
  2. Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 1, 2025 to Feb 19, 2025
    v4
  3. Primary completion date: Dec 31, 2025 to Dec 31, 2027v3 Show 5 more changesShow less
    • Start date: Oct 1, 2024 to Jan 1, 2025
    • Study completion date: May 15, 2026 to May 15, 2028
    • Eligibility criteria shortened, about 8 words
    • Secondary endpoints revised (15)
    • Study description revised
  4. Primary completion date: Dec 31, 2024 to Dec 31, 2025
    • Start date: Jan 1, 2022 to Oct 1, 2024
    • Study completion date: May 15, 2025 to May 15, 2026
    • Secondary endpoints: details revised at 1 of 15 entries
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is intended to test the hypothesis that sodium lactate infusion after resuscitation from a cardiac arrest will decrease the magnitude of brain damage, as measured by the serum biomarker concentration of NSE.
Trial Details
NCT Number NCT05004610
Lead Sponsor Erasme University Hospital
Conditions
(from sponsor)		 Cardiac Arrest, Ischemia Reperfusion Injury, Anoxic Brain Injury
Related terms Heart Arrest, Hypoxia-Ischemia, Brain, Reperfusion Injury
Enrollment 125 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov